Impact of Roflumilast on Visceral Adiposity and Metabolic Profile in Chronic Obstructive Pulmonary Disease (RAMBO)
This study has been terminated.
(The recruitment of the study was prematurely stopped in July 2014 for the following reason; no more study medication.)
First Posted: October 5, 2012
Last Update Posted: November 11, 2014
Information provided by (Responsible Party):